nodes	percent_of_prediction	percent_of_DWPC	metapath
Pyrazinamide—CYP1A2—Gemfibrozil—coronary artery disease	0.0779	0.137	CbGbCtD
Pyrazinamide—CYP1A2—Clopidogrel—coronary artery disease	0.0676	0.119	CbGbCtD
Pyrazinamide—CYP3A4—Ticagrelor—coronary artery disease	0.0573	0.101	CbGbCtD
Pyrazinamide—CYP3A4—Fenofibrate—coronary artery disease	0.0511	0.0896	CbGbCtD
Pyrazinamide—CYP3A4—Gemfibrozil—coronary artery disease	0.0408	0.0716	CbGbCtD
Pyrazinamide—CYP3A4—Clopidogrel—coronary artery disease	0.0354	0.0621	CbGbCtD
Pyrazinamide—CYP1A2—Losartan—coronary artery disease	0.033	0.0579	CbGbCtD
Pyrazinamide—CYP3A4—Eplerenone—coronary artery disease	0.0329	0.0577	CbGbCtD
Pyrazinamide—CYP3A4—Enalapril—coronary artery disease	0.0293	0.0515	CbGbCtD
Pyrazinamide—CYP3A4—Ezetimibe—coronary artery disease	0.0228	0.04	CbGbCtD
Pyrazinamide—CYP3A4—Rosuvastatin—coronary artery disease	0.0228	0.04	CbGbCtD
Pyrazinamide—CYP3A4—Simvastatin—coronary artery disease	0.0212	0.0372	CbGbCtD
Pyrazinamide—CYP3A4—Pravastatin—coronary artery disease	0.0207	0.0364	CbGbCtD
Pyrazinamide—CYP3A4—Lovastatin—coronary artery disease	0.0207	0.0364	CbGbCtD
Pyrazinamide—CYP3A4—Atorvastatin—coronary artery disease	0.0189	0.0332	CbGbCtD
Pyrazinamide—CYP3A4—Losartan—coronary artery disease	0.0173	0.0303	CbGbCtD
Pyrazinamide—Discomfort—Perindopril—coronary artery disease	0.000352	0.00121	CcSEcCtD
Pyrazinamide—Anorexia—Trandolapril—coronary artery disease	0.000351	0.00121	CcSEcCtD
Pyrazinamide—Musculoskeletal discomfort—Niacin—coronary artery disease	0.00035	0.00121	CcSEcCtD
Pyrazinamide—Hepatitis—Lisinopril—coronary artery disease	0.00035	0.00121	CcSEcCtD
Pyrazinamide—Anorexia—Enalapril—coronary artery disease	0.000349	0.0012	CcSEcCtD
Pyrazinamide—Urticaria—Ezetimibe—coronary artery disease	0.000349	0.0012	CcSEcCtD
Pyrazinamide—Nausea—Ticagrelor—coronary artery disease	0.000349	0.0012	CcSEcCtD
Pyrazinamide—Dyspepsia—Valsartan—coronary artery disease	0.000348	0.0012	CcSEcCtD
Pyrazinamide—Body temperature increased—Ezetimibe—coronary artery disease	0.000347	0.0012	CcSEcCtD
Pyrazinamide—Dyspepsia—Olmesartan—coronary artery disease	0.000347	0.00119	CcSEcCtD
Pyrazinamide—Feeling abnormal—Simvastatin—coronary artery disease	0.000345	0.00119	CcSEcCtD
Pyrazinamide—Musculoskeletal discomfort—Pravastatin—coronary artery disease	0.000345	0.00119	CcSEcCtD
Pyrazinamide—Anorexia—Telmisartan—coronary artery disease	0.000344	0.00119	CcSEcCtD
Pyrazinamide—Thrombocytopenia—Captopril—coronary artery disease	0.000344	0.00118	CcSEcCtD
Pyrazinamide—Decreased appetite—Valsartan—coronary artery disease	0.000344	0.00118	CcSEcCtD
Pyrazinamide—Decreased appetite—Olmesartan—coronary artery disease	0.000342	0.00118	CcSEcCtD
Pyrazinamide—Gastrointestinal disorder—Valsartan—coronary artery disease	0.000342	0.00118	CcSEcCtD
Pyrazinamide—Gastrointestinal disorder—Olmesartan—coronary artery disease	0.00034	0.00117	CcSEcCtD
Pyrazinamide—Body temperature increased—Eplerenone—coronary artery disease	0.00034	0.00117	CcSEcCtD
Pyrazinamide—Dyspepsia—Niacin—coronary artery disease	0.000339	0.00117	CcSEcCtD
Pyrazinamide—Hypersensitivity—Fenofibrate—coronary artery disease	0.000338	0.00116	CcSEcCtD
Pyrazinamide—Musculoskeletal discomfort—Trandolapril—coronary artery disease	0.000335	0.00115	CcSEcCtD
Pyrazinamide—Anorexia—Captopril—coronary artery disease	0.000335	0.00115	CcSEcCtD
Pyrazinamide—Decreased appetite—Niacin—coronary artery disease	0.000334	0.00115	CcSEcCtD
Pyrazinamide—Thrombocytopenia—Perindopril—coronary artery disease	0.000334	0.00115	CcSEcCtD
Pyrazinamide—Arthralgia—Losartan—coronary artery disease	0.000334	0.00115	CcSEcCtD
Pyrazinamide—Myalgia—Losartan—coronary artery disease	0.000334	0.00115	CcSEcCtD
Pyrazinamide—Musculoskeletal discomfort—Enalapril—coronary artery disease	0.000334	0.00115	CcSEcCtD
Pyrazinamide—Dyspepsia—Pravastatin—coronary artery disease	0.000333	0.00115	CcSEcCtD
Pyrazinamide—Rash—Rosuvastatin—coronary artery disease	0.000333	0.00115	CcSEcCtD
Pyrazinamide—Dermatitis—Rosuvastatin—coronary artery disease	0.000333	0.00115	CcSEcCtD
Pyrazinamide—Urticaria—Simvastatin—coronary artery disease	0.000333	0.00115	CcSEcCtD
Pyrazinamide—Hypersensitivity—Clopidogrel—coronary artery disease	0.000332	0.00114	CcSEcCtD
Pyrazinamide—Gastrointestinal disorder—Niacin—coronary artery disease	0.000332	0.00114	CcSEcCtD
Pyrazinamide—Body temperature increased—Simvastatin—coronary artery disease	0.000331	0.00114	CcSEcCtD
Pyrazinamide—Hypersensitivity—Lovastatin—coronary artery disease	0.00033	0.00114	CcSEcCtD
Pyrazinamide—Discomfort—Losartan—coronary artery disease	0.00033	0.00114	CcSEcCtD
Pyrazinamide—Decreased appetite—Pravastatin—coronary artery disease	0.000329	0.00113	CcSEcCtD
Pyrazinamide—Musculoskeletal discomfort—Telmisartan—coronary artery disease	0.000329	0.00113	CcSEcCtD
Pyrazinamide—Vomiting—Acetylsalicylic acid—coronary artery disease	0.000326	0.00112	CcSEcCtD
Pyrazinamide—Anorexia—Perindopril—coronary artery disease	0.000325	0.00112	CcSEcCtD
Pyrazinamide—Thrombocytopenia—Furosemide—coronary artery disease	0.000325	0.00112	CcSEcCtD
Pyrazinamide—Pruritus—Fenofibrate—coronary artery disease	0.000325	0.00112	CcSEcCtD
Pyrazinamide—Feeling abnormal—Olmesartan—coronary artery disease	0.000324	0.00112	CcSEcCtD
Pyrazinamide—Dyspepsia—Trandolapril—coronary artery disease	0.000324	0.00112	CcSEcCtD
Pyrazinamide—Rash—Acetylsalicylic acid—coronary artery disease	0.000324	0.00111	CcSEcCtD
Pyrazinamide—Hypersensitivity—Ezetimibe—coronary artery disease	0.000324	0.00111	CcSEcCtD
Pyrazinamide—Dermatitis—Acetylsalicylic acid—coronary artery disease	0.000323	0.00111	CcSEcCtD
Pyrazinamide—Dyspepsia—Enalapril—coronary artery disease	0.000322	0.00111	CcSEcCtD
Pyrazinamide—Musculoskeletal discomfort—Captopril—coronary artery disease	0.00032	0.0011	CcSEcCtD
Pyrazinamide—Decreased appetite—Trandolapril—coronary artery disease	0.00032	0.0011	CcSEcCtD
Pyrazinamide—Pruritus—Clopidogrel—coronary artery disease	0.000319	0.0011	CcSEcCtD
Pyrazinamide—Decreased appetite—Enalapril—coronary artery disease	0.000318	0.0011	CcSEcCtD
Pyrazinamide—Dyspepsia—Telmisartan—coronary artery disease	0.000318	0.0011	CcSEcCtD
Pyrazinamide—Gastrointestinal disorder—Trandolapril—coronary artery disease	0.000318	0.00109	CcSEcCtD
Pyrazinamide—Pruritus—Lovastatin—coronary artery disease	0.000317	0.00109	CcSEcCtD
Pyrazinamide—Anorexia—Furosemide—coronary artery disease	0.000316	0.00109	CcSEcCtD
Pyrazinamide—Urticaria—Valsartan—coronary artery disease	0.000314	0.00108	CcSEcCtD
Pyrazinamide—Decreased appetite—Telmisartan—coronary artery disease	0.000314	0.00108	CcSEcCtD
Pyrazinamide—Nausea—Rosuvastatin—coronary artery disease	0.000314	0.00108	CcSEcCtD
Pyrazinamide—Thrombocytopenia—Losartan—coronary artery disease	0.000313	0.00108	CcSEcCtD
Pyrazinamide—Urticaria—Olmesartan—coronary artery disease	0.000313	0.00108	CcSEcCtD
Pyrazinamide—Feeling abnormal—Pravastatin—coronary artery disease	0.000312	0.00107	CcSEcCtD
Pyrazinamide—Gastrointestinal disorder—Telmisartan—coronary artery disease	0.000312	0.00107	CcSEcCtD
Pyrazinamide—Ill-defined disorder—Ramipril—coronary artery disease	0.000312	0.00107	CcSEcCtD
Pyrazinamide—Body temperature increased—Olmesartan—coronary artery disease	0.000311	0.00107	CcSEcCtD
Pyrazinamide—Pruritus—Ezetimibe—coronary artery disease	0.000311	0.00107	CcSEcCtD
Pyrazinamide—Musculoskeletal discomfort—Perindopril—coronary artery disease	0.000311	0.00107	CcSEcCtD
Pyrazinamide—Dyspepsia—Captopril—coronary artery disease	0.000309	0.00107	CcSEcCtD
Pyrazinamide—Hypersensitivity—Simvastatin—coronary artery disease	0.000309	0.00106	CcSEcCtD
Pyrazinamide—Urticaria—Niacin—coronary artery disease	0.000306	0.00105	CcSEcCtD
Pyrazinamide—Decreased appetite—Captopril—coronary artery disease	0.000305	0.00105	CcSEcCtD
Pyrazinamide—Anorexia—Losartan—coronary artery disease	0.000305	0.00105	CcSEcCtD
Pyrazinamide—Nausea—Acetylsalicylic acid—coronary artery disease	0.000305	0.00105	CcSEcCtD
Pyrazinamide—Pruritus—Eplerenone—coronary artery disease	0.000304	0.00105	CcSEcCtD
Pyrazinamide—Body temperature increased—Niacin—coronary artery disease	0.000304	0.00105	CcSEcCtD
Pyrazinamide—Malaise—Ramipril—coronary artery disease	0.000303	0.00104	CcSEcCtD
Pyrazinamide—Feeling abnormal—Trandolapril—coronary artery disease	0.000303	0.00104	CcSEcCtD
Pyrazinamide—Feeling abnormal—Enalapril—coronary artery disease	0.000302	0.00104	CcSEcCtD
Pyrazinamide—Urticaria—Pravastatin—coronary artery disease	0.000301	0.00104	CcSEcCtD
Pyrazinamide—Dyspepsia—Perindopril—coronary artery disease	0.0003	0.00103	CcSEcCtD
Pyrazinamide—Body temperature increased—Pravastatin—coronary artery disease	0.000299	0.00103	CcSEcCtD
Pyrazinamide—Feeling abnormal—Telmisartan—coronary artery disease	0.000298	0.00103	CcSEcCtD
Pyrazinamide—Decreased appetite—Perindopril—coronary artery disease	0.000297	0.00102	CcSEcCtD
Pyrazinamide—Pruritus—Simvastatin—coronary artery disease	0.000296	0.00102	CcSEcCtD
Pyrazinamide—Gastrointestinal disorder—Perindopril—coronary artery disease	0.000295	0.00101	CcSEcCtD
Pyrazinamide—Urticaria—Trandolapril—coronary artery disease	0.000292	0.00101	CcSEcCtD
Pyrazinamide—Vomiting—Fenofibrate—coronary artery disease	0.000292	0.001	CcSEcCtD
Pyrazinamide—Musculoskeletal discomfort—Losartan—coronary artery disease	0.000292	0.001	CcSEcCtD
Pyrazinamide—Hypersensitivity—Valsartan—coronary artery disease	0.000291	0.001	CcSEcCtD
Pyrazinamide—Urticaria—Enalapril—coronary artery disease	0.000291	0.001	CcSEcCtD
Pyrazinamide—Body temperature increased—Trandolapril—coronary artery disease	0.000291	0.001	CcSEcCtD
Pyrazinamide—Body temperature increased—Enalapril—coronary artery disease	0.00029	0.000997	CcSEcCtD
Pyrazinamide—Feeling abnormal—Captopril—coronary artery disease	0.00029	0.000997	CcSEcCtD
Pyrazinamide—Rash—Fenofibrate—coronary artery disease	0.000289	0.000996	CcSEcCtD
Pyrazinamide—Dermatitis—Fenofibrate—coronary artery disease	0.000289	0.000995	CcSEcCtD
Pyrazinamide—Decreased appetite—Furosemide—coronary artery disease	0.000288	0.000993	CcSEcCtD
Pyrazinamide—Urticaria—Telmisartan—coronary artery disease	0.000287	0.000989	CcSEcCtD
Pyrazinamide—Vomiting—Clopidogrel—coronary artery disease	0.000287	0.000987	CcSEcCtD
Pyrazinamide—Gastrointestinal disorder—Furosemide—coronary artery disease	0.000286	0.000986	CcSEcCtD
Pyrazinamide—Myalgia—Ramipril—coronary artery disease	0.000286	0.000986	CcSEcCtD
Pyrazinamide—Arthralgia—Ramipril—coronary artery disease	0.000286	0.000986	CcSEcCtD
Pyrazinamide—Body temperature increased—Telmisartan—coronary artery disease	0.000286	0.000984	CcSEcCtD
Pyrazinamide—Vomiting—Lovastatin—coronary artery disease	0.000285	0.000981	CcSEcCtD
Pyrazinamide—Rash—Clopidogrel—coronary artery disease	0.000284	0.000979	CcSEcCtD
Pyrazinamide—Dermatitis—Clopidogrel—coronary artery disease	0.000284	0.000978	CcSEcCtD
Pyrazinamide—Hypersensitivity—Niacin—coronary artery disease	0.000283	0.000976	CcSEcCtD
Pyrazinamide—Ill-defined disorder—Lisinopril—coronary artery disease	0.000283	0.000974	CcSEcCtD
Pyrazinamide—Discomfort—Ramipril—coronary artery disease	0.000283	0.000974	CcSEcCtD
Pyrazinamide—Rash—Lovastatin—coronary artery disease	0.000282	0.000973	CcSEcCtD
Pyrazinamide—Dermatitis—Lovastatin—coronary artery disease	0.000282	0.000972	CcSEcCtD
Pyrazinamide—Dyspepsia—Losartan—coronary artery disease	0.000282	0.00097	CcSEcCtD
Pyrazinamide—Feeling abnormal—Perindopril—coronary artery disease	0.000281	0.000968	CcSEcCtD
Pyrazinamide—Pruritus—Valsartan—coronary artery disease	0.00028	0.000964	CcSEcCtD
Pyrazinamide—Arthralgia—Timolol—coronary artery disease	0.00028	0.000964	CcSEcCtD
Pyrazinamide—Myalgia—Timolol—coronary artery disease	0.00028	0.000964	CcSEcCtD
Pyrazinamide—Vomiting—Ezetimibe—coronary artery disease	0.000279	0.000962	CcSEcCtD
Pyrazinamide—Hypersensitivity—Pravastatin—coronary artery disease	0.000279	0.000961	CcSEcCtD
Pyrazinamide—Pruritus—Olmesartan—coronary artery disease	0.000279	0.000959	CcSEcCtD
Pyrazinamide—Decreased appetite—Losartan—coronary artery disease	0.000278	0.000958	CcSEcCtD
Pyrazinamide—Body temperature increased—Captopril—coronary artery disease	0.000278	0.000957	CcSEcCtD
Pyrazinamide—Rash—Ezetimibe—coronary artery disease	0.000277	0.000954	CcSEcCtD
Pyrazinamide—Dermatitis—Ezetimibe—coronary artery disease	0.000277	0.000953	CcSEcCtD
Pyrazinamide—Discomfort—Timolol—coronary artery disease	0.000276	0.000952	CcSEcCtD
Pyrazinamide—Malaise—Lisinopril—coronary artery disease	0.000275	0.000947	CcSEcCtD
Pyrazinamide—Vomiting—Eplerenone—coronary artery disease	0.000273	0.000942	CcSEcCtD
Pyrazinamide—Feeling abnormal—Furosemide—coronary artery disease	0.000273	0.000941	CcSEcCtD
Pyrazinamide—Nausea—Fenofibrate—coronary artery disease	0.000272	0.000938	CcSEcCtD
Pyrazinamide—Pruritus—Niacin—coronary artery disease	0.000272	0.000937	CcSEcCtD
Pyrazinamide—Rash—Eplerenone—coronary artery disease	0.000271	0.000934	CcSEcCtD
Pyrazinamide—Urticaria—Perindopril—coronary artery disease	0.000271	0.000933	CcSEcCtD
Pyrazinamide—Hypersensitivity—Trandolapril—coronary artery disease	0.000271	0.000933	CcSEcCtD
Pyrazinamide—Dermatitis—Eplerenone—coronary artery disease	0.000271	0.000933	CcSEcCtD
Pyrazinamide—Hypersensitivity—Enalapril—coronary artery disease	0.00027	0.00093	CcSEcCtD
Pyrazinamide—Body temperature increased—Perindopril—coronary artery disease	0.00027	0.000929	CcSEcCtD
Pyrazinamide—Thrombocytopenia—Ramipril—coronary artery disease	0.000269	0.000925	CcSEcCtD
Pyrazinamide—Pruritus—Pravastatin—coronary artery disease	0.000268	0.000923	CcSEcCtD
Pyrazinamide—Nausea—Clopidogrel—coronary artery disease	0.000268	0.000922	CcSEcCtD
Pyrazinamide—Vomiting—Simvastatin—coronary artery disease	0.000266	0.000917	CcSEcCtD
Pyrazinamide—Hypersensitivity—Telmisartan—coronary artery disease	0.000266	0.000917	CcSEcCtD
Pyrazinamide—Nausea—Lovastatin—coronary artery disease	0.000266	0.000916	CcSEcCtD
Pyrazinamide—Rash—Simvastatin—coronary artery disease	0.000264	0.00091	CcSEcCtD
Pyrazinamide—Dermatitis—Simvastatin—coronary artery disease	0.000264	0.000909	CcSEcCtD
Pyrazinamide—Feeling abnormal—Losartan—coronary artery disease	0.000264	0.000908	CcSEcCtD
Pyrazinamide—Urticaria—Furosemide—coronary artery disease	0.000263	0.000907	CcSEcCtD
Pyrazinamide—Body temperature increased—Furosemide—coronary artery disease	0.000262	0.000903	CcSEcCtD
Pyrazinamide—Anorexia—Ramipril—coronary artery disease	0.000262	0.000901	CcSEcCtD
Pyrazinamide—Nausea—Ezetimibe—coronary artery disease	0.000261	0.000899	CcSEcCtD
Pyrazinamide—Pruritus—Trandolapril—coronary artery disease	0.00026	0.000896	CcSEcCtD
Pyrazinamide—Myalgia—Lisinopril—coronary artery disease	0.00026	0.000894	CcSEcCtD
Pyrazinamide—Arthralgia—Lisinopril—coronary artery disease	0.00026	0.000894	CcSEcCtD
Pyrazinamide—Pruritus—Enalapril—coronary artery disease	0.000259	0.000893	CcSEcCtD
Pyrazinamide—Discomfort—Lisinopril—coronary artery disease	0.000256	0.000883	CcSEcCtD
Pyrazinamide—Anorexia—Timolol—coronary artery disease	0.000256	0.000881	CcSEcCtD
Pyrazinamide—Pruritus—Telmisartan—coronary artery disease	0.000256	0.00088	CcSEcCtD
Pyrazinamide—Nausea—Eplerenone—coronary artery disease	0.000255	0.00088	CcSEcCtD
Pyrazinamide—Urticaria—Losartan—coronary artery disease	0.000254	0.000875	CcSEcCtD
Pyrazinamide—Body temperature increased—Losartan—coronary artery disease	0.000253	0.000871	CcSEcCtD
Pyrazinamide—Vomiting—Valsartan—coronary artery disease	0.000252	0.000866	CcSEcCtD
Pyrazinamide—Vomiting—Olmesartan—coronary artery disease	0.00025	0.000862	CcSEcCtD
Pyrazinamide—Musculoskeletal discomfort—Ramipril—coronary artery disease	0.00025	0.000861	CcSEcCtD
Pyrazinamide—Rash—Valsartan—coronary artery disease	0.000249	0.000859	CcSEcCtD
Pyrazinamide—Dermatitis—Valsartan—coronary artery disease	0.000249	0.000858	CcSEcCtD
Pyrazinamide—Nausea—Simvastatin—coronary artery disease	0.000249	0.000857	CcSEcCtD
Pyrazinamide—Pruritus—Captopril—coronary artery disease	0.000249	0.000856	CcSEcCtD
Pyrazinamide—Rash—Olmesartan—coronary artery disease	0.000248	0.000855	CcSEcCtD
Pyrazinamide—Dermatitis—Olmesartan—coronary artery disease	0.000248	0.000854	CcSEcCtD
Pyrazinamide—Vomiting—Niacin—coronary artery disease	0.000245	0.000842	CcSEcCtD
Pyrazinamide—Musculoskeletal discomfort—Timolol—coronary artery disease	0.000244	0.000842	CcSEcCtD
Pyrazinamide—Hypersensitivity—Furosemide—coronary artery disease	0.000244	0.000841	CcSEcCtD
Pyrazinamide—Thrombocytopenia—Lisinopril—coronary artery disease	0.000244	0.000839	CcSEcCtD
Pyrazinamide—Rash—Niacin—coronary artery disease	0.000243	0.000835	CcSEcCtD
Pyrazinamide—Dermatitis—Niacin—coronary artery disease	0.000242	0.000835	CcSEcCtD
Pyrazinamide—Dyspepsia—Ramipril—coronary artery disease	0.000242	0.000832	CcSEcCtD
Pyrazinamide—Pruritus—Perindopril—coronary artery disease	0.000241	0.000831	CcSEcCtD
Pyrazinamide—Vomiting—Pravastatin—coronary artery disease	0.000241	0.000829	CcSEcCtD
Pyrazinamide—Rash—Pravastatin—coronary artery disease	0.000239	0.000822	CcSEcCtD
Pyrazinamide—Dermatitis—Pravastatin—coronary artery disease	0.000239	0.000822	CcSEcCtD
Pyrazinamide—Decreased appetite—Ramipril—coronary artery disease	0.000239	0.000821	CcSEcCtD
Pyrazinamide—Anorexia—Lisinopril—coronary artery disease	0.000237	0.000817	CcSEcCtD
Pyrazinamide—Gastrointestinal disorder—Ramipril—coronary artery disease	0.000237	0.000816	CcSEcCtD
Pyrazinamide—Dyspepsia—Timolol—coronary artery disease	0.000236	0.000813	CcSEcCtD
Pyrazinamide—Hypersensitivity—Losartan—coronary artery disease	0.000236	0.000812	CcSEcCtD
Pyrazinamide—Nausea—Valsartan—coronary artery disease	0.000235	0.000809	CcSEcCtD
Pyrazinamide—Pruritus—Furosemide—coronary artery disease	0.000235	0.000808	CcSEcCtD
Pyrazinamide—Nausea—Olmesartan—coronary artery disease	0.000234	0.000805	CcSEcCtD
Pyrazinamide—Vomiting—Trandolapril—coronary artery disease	0.000234	0.000805	CcSEcCtD
Pyrazinamide—Decreased appetite—Timolol—coronary artery disease	0.000233	0.000803	CcSEcCtD
Pyrazinamide—Vomiting—Enalapril—coronary artery disease	0.000233	0.000802	CcSEcCtD
Pyrazinamide—Rash—Trandolapril—coronary artery disease	0.000232	0.000799	CcSEcCtD
Pyrazinamide—Dermatitis—Trandolapril—coronary artery disease	0.000232	0.000798	CcSEcCtD
Pyrazinamide—Gastrointestinal disorder—Timolol—coronary artery disease	0.000232	0.000797	CcSEcCtD
Pyrazinamide—Rash—Enalapril—coronary artery disease	0.000231	0.000795	CcSEcCtD
Pyrazinamide—Dermatitis—Enalapril—coronary artery disease	0.000231	0.000795	CcSEcCtD
Pyrazinamide—Vomiting—Telmisartan—coronary artery disease	0.00023	0.000791	CcSEcCtD
Pyrazinamide—Nausea—Niacin—coronary artery disease	0.000228	0.000787	CcSEcCtD
Pyrazinamide—Rash—Telmisartan—coronary artery disease	0.000228	0.000785	CcSEcCtD
Pyrazinamide—Dermatitis—Telmisartan—coronary artery disease	0.000228	0.000784	CcSEcCtD
Pyrazinamide—Musculoskeletal discomfort—Lisinopril—coronary artery disease	0.000227	0.000781	CcSEcCtD
Pyrazinamide—Pruritus—Losartan—coronary artery disease	0.000226	0.00078	CcSEcCtD
Pyrazinamide—Feeling abnormal—Ramipril—coronary artery disease	0.000226	0.000779	CcSEcCtD
Pyrazinamide—Nausea—Pravastatin—coronary artery disease	0.000225	0.000775	CcSEcCtD
Pyrazinamide—Vomiting—Captopril—coronary artery disease	0.000223	0.000769	CcSEcCtD
Pyrazinamide—Rash—Captopril—coronary artery disease	0.000222	0.000763	CcSEcCtD
Pyrazinamide—Dermatitis—Captopril—coronary artery disease	0.000221	0.000762	CcSEcCtD
Pyrazinamide—Feeling abnormal—Timolol—coronary artery disease	0.000221	0.000761	CcSEcCtD
Pyrazinamide—Dyspepsia—Lisinopril—coronary artery disease	0.000219	0.000754	CcSEcCtD
Pyrazinamide—Nausea—Trandolapril—coronary artery disease	0.000218	0.000752	CcSEcCtD
Pyrazinamide—Urticaria—Ramipril—coronary artery disease	0.000218	0.000751	CcSEcCtD
Pyrazinamide—Nausea—Enalapril—coronary artery disease	0.000218	0.000749	CcSEcCtD
Pyrazinamide—Vomiting—Perindopril—coronary artery disease	0.000217	0.000747	CcSEcCtD
Pyrazinamide—Body temperature increased—Ramipril—coronary artery disease	0.000217	0.000747	CcSEcCtD
Pyrazinamide—Decreased appetite—Lisinopril—coronary artery disease	0.000216	0.000745	CcSEcCtD
Pyrazinamide—Rash—Perindopril—coronary artery disease	0.000215	0.000741	CcSEcCtD
Pyrazinamide—Dermatitis—Perindopril—coronary artery disease	0.000215	0.00074	CcSEcCtD
Pyrazinamide—Gastrointestinal disorder—Lisinopril—coronary artery disease	0.000215	0.00074	CcSEcCtD
Pyrazinamide—Nausea—Telmisartan—coronary artery disease	0.000215	0.000739	CcSEcCtD
Pyrazinamide—Urticaria—Timolol—coronary artery disease	0.000213	0.000734	CcSEcCtD
Pyrazinamide—Body temperature increased—Timolol—coronary artery disease	0.000212	0.00073	CcSEcCtD
Pyrazinamide—Vomiting—Furosemide—coronary artery disease	0.000211	0.000726	CcSEcCtD
Pyrazinamide—Rash—Furosemide—coronary artery disease	0.000209	0.00072	CcSEcCtD
Pyrazinamide—Dermatitis—Furosemide—coronary artery disease	0.000209	0.000719	CcSEcCtD
Pyrazinamide—Nausea—Captopril—coronary artery disease	0.000209	0.000719	CcSEcCtD
Pyrazinamide—Feeling abnormal—Lisinopril—coronary artery disease	0.000205	0.000706	CcSEcCtD
Pyrazinamide—Vomiting—Losartan—coronary artery disease	0.000203	0.000701	CcSEcCtD
Pyrazinamide—Nausea—Perindopril—coronary artery disease	0.000203	0.000698	CcSEcCtD
Pyrazinamide—Hypersensitivity—Ramipril—coronary artery disease	0.000202	0.000696	CcSEcCtD
Pyrazinamide—Rash—Losartan—coronary artery disease	0.000202	0.000695	CcSEcCtD
Pyrazinamide—Dermatitis—Losartan—coronary artery disease	0.000202	0.000694	CcSEcCtD
Pyrazinamide—Urticaria—Lisinopril—coronary artery disease	0.000198	0.000681	CcSEcCtD
Pyrazinamide—Hypersensitivity—Timolol—coronary artery disease	0.000198	0.000681	CcSEcCtD
Pyrazinamide—Nausea—Furosemide—coronary artery disease	0.000197	0.000678	CcSEcCtD
Pyrazinamide—Body temperature increased—Lisinopril—coronary artery disease	0.000197	0.000677	CcSEcCtD
Pyrazinamide—Pruritus—Ramipril—coronary artery disease	0.000194	0.000669	CcSEcCtD
Pyrazinamide—Nausea—Losartan—coronary artery disease	0.00019	0.000655	CcSEcCtD
Pyrazinamide—Pruritus—Timolol—coronary artery disease	0.00019	0.000654	CcSEcCtD
Pyrazinamide—Hypersensitivity—Lisinopril—coronary artery disease	0.000183	0.000631	CcSEcCtD
Pyrazinamide—Pruritus—Lisinopril—coronary artery disease	0.000176	0.000606	CcSEcCtD
Pyrazinamide—Vomiting—Ramipril—coronary artery disease	0.000174	0.000601	CcSEcCtD
Pyrazinamide—Rash—Ramipril—coronary artery disease	0.000173	0.000596	CcSEcCtD
Pyrazinamide—Dermatitis—Ramipril—coronary artery disease	0.000173	0.000595	CcSEcCtD
Pyrazinamide—Vomiting—Timolol—coronary artery disease	0.000171	0.000587	CcSEcCtD
Pyrazinamide—Rash—Timolol—coronary artery disease	0.000169	0.000582	CcSEcCtD
Pyrazinamide—Dermatitis—Timolol—coronary artery disease	0.000169	0.000582	CcSEcCtD
Pyrazinamide—Nausea—Ramipril—coronary artery disease	0.000163	0.000561	CcSEcCtD
Pyrazinamide—Nausea—Timolol—coronary artery disease	0.000159	0.000549	CcSEcCtD
Pyrazinamide—Vomiting—Lisinopril—coronary artery disease	0.000158	0.000545	CcSEcCtD
Pyrazinamide—Rash—Lisinopril—coronary artery disease	0.000157	0.00054	CcSEcCtD
Pyrazinamide—Dermatitis—Lisinopril—coronary artery disease	0.000157	0.00054	CcSEcCtD
Pyrazinamide—Nausea—Lisinopril—coronary artery disease	0.000148	0.000509	CcSEcCtD
Pyrazinamide—CYP1A2—Metabolism—PYGM—coronary artery disease	3.09e-05	0.000221	CbGpPWpGaD
Pyrazinamide—CYP1A2—Metabolism—CKMT2—coronary artery disease	3.09e-05	0.000221	CbGpPWpGaD
Pyrazinamide—CYP1A2—Metabolism—ALDH6A1—coronary artery disease	3.09e-05	0.000221	CbGpPWpGaD
Pyrazinamide—CYP1A2—Biological oxidations—POMC—coronary artery disease	3.08e-05	0.00022	CbGpPWpGaD
Pyrazinamide—XDH—Metabolism—AGT—coronary artery disease	2.98e-05	0.000213	CbGpPWpGaD
Pyrazinamide—AOX1—Disease—SERPINE1—coronary artery disease	2.94e-05	0.00021	CbGpPWpGaD
Pyrazinamide—XDH—Metabolism—APOE—coronary artery disease	2.92e-05	0.000209	CbGpPWpGaD
Pyrazinamide—XDH—Metabolism—APOA1—coronary artery disease	2.89e-05	0.000206	CbGpPWpGaD
Pyrazinamide—AOX1—Disease—FGF2—coronary artery disease	2.85e-05	0.000204	CbGpPWpGaD
Pyrazinamide—AOX1—Disease—NOS3—coronary artery disease	2.81e-05	0.000201	CbGpPWpGaD
Pyrazinamide—CYP1A2—Metabolism—HMGCS2—coronary artery disease	2.76e-05	0.000197	CbGpPWpGaD
Pyrazinamide—CYP1A2—Metabolism—GK—coronary artery disease	2.76e-05	0.000197	CbGpPWpGaD
Pyrazinamide—CYP1A2—Metabolism—GYG1—coronary artery disease	2.76e-05	0.000197	CbGpPWpGaD
Pyrazinamide—CYP1A2—Metabolism—LDHA—coronary artery disease	2.76e-05	0.000197	CbGpPWpGaD
Pyrazinamide—CYP1A2—Metabolism—PFKM—coronary artery disease	2.76e-05	0.000197	CbGpPWpGaD
Pyrazinamide—CYP1A2—Metabolism—GATM—coronary artery disease	2.76e-05	0.000197	CbGpPWpGaD
Pyrazinamide—AOX1—Metabolism—PPARG—coronary artery disease	2.73e-05	0.000196	CbGpPWpGaD
Pyrazinamide—AOX1—Disease—JAK2—coronary artery disease	2.73e-05	0.000195	CbGpPWpGaD
Pyrazinamide—AOX1—Metabolism—POMC—coronary artery disease	2.7e-05	0.000193	CbGpPWpGaD
Pyrazinamide—CYP1A2—Metabolism of lipids and lipoproteins—LIPC—coronary artery disease	2.69e-05	0.000193	CbGpPWpGaD
Pyrazinamide—CYP1A2—Metabolism of lipids and lipoproteins—PIK3C2A—coronary artery disease	2.69e-05	0.000193	CbGpPWpGaD
Pyrazinamide—CYP1A2—Metabolism of lipids and lipoproteins—CYP2C19—coronary artery disease	2.69e-05	0.000193	CbGpPWpGaD
Pyrazinamide—CYP1A2—Metabolism of lipids and lipoproteins—APOC3—coronary artery disease	2.68e-05	0.000191	CbGpPWpGaD
Pyrazinamide—CYP1A2—Metabolism of lipids and lipoproteins—LDLR—coronary artery disease	2.66e-05	0.00019	CbGpPWpGaD
Pyrazinamide—CYP1A2—Metabolism—AK1—coronary artery disease	2.63e-05	0.000188	CbGpPWpGaD
Pyrazinamide—CYP1A2—Metabolism—GCH1—coronary artery disease	2.63e-05	0.000188	CbGpPWpGaD
Pyrazinamide—CYP1A2—Metabolism of lipids and lipoproteins—CETP—coronary artery disease	2.6e-05	0.000186	CbGpPWpGaD
Pyrazinamide—CYP1A2—Metabolism of lipids and lipoproteins—SDC1—coronary artery disease	2.57e-05	0.000184	CbGpPWpGaD
Pyrazinamide—AOX1—Disease—PTGS2—coronary artery disease	2.57e-05	0.000184	CbGpPWpGaD
Pyrazinamide—CYP3A4—Metabolism—PPAP2B—coronary artery disease	2.57e-05	0.000184	CbGpPWpGaD
Pyrazinamide—CYP3A4—Metabolism—UQCRFS1—coronary artery disease	2.57e-05	0.000184	CbGpPWpGaD
Pyrazinamide—CYP3A4—Metabolism—CKM—coronary artery disease	2.57e-05	0.000184	CbGpPWpGaD
Pyrazinamide—XDH—Metabolism—PPARG—coronary artery disease	2.54e-05	0.000182	CbGpPWpGaD
Pyrazinamide—CYP1A2—Metabolism—PLCD1—coronary artery disease	2.52e-05	0.00018	CbGpPWpGaD
Pyrazinamide—CYP1A2—Metabolism—PPAT—coronary artery disease	2.52e-05	0.00018	CbGpPWpGaD
Pyrazinamide—CYP1A2—Metabolism—UGCG—coronary artery disease	2.52e-05	0.00018	CbGpPWpGaD
Pyrazinamide—CYP1A2—Metabolism—MDH2—coronary artery disease	2.52e-05	0.00018	CbGpPWpGaD
Pyrazinamide—XDH—Metabolism—POMC—coronary artery disease	2.51e-05	0.000179	CbGpPWpGaD
Pyrazinamide—AOX1—Metabolism—ALB—coronary artery disease	2.46e-05	0.000176	CbGpPWpGaD
Pyrazinamide—CYP1A2—Metabolism—PGM1—coronary artery disease	2.43e-05	0.000174	CbGpPWpGaD
Pyrazinamide—CYP3A4—Metabolism—PDK4—coronary artery disease	2.39e-05	0.000171	CbGpPWpGaD
Pyrazinamide—CYP3A4—Metabolism—CKMT2—coronary artery disease	2.39e-05	0.000171	CbGpPWpGaD
Pyrazinamide—CYP3A4—Metabolism—ALDH6A1—coronary artery disease	2.39e-05	0.000171	CbGpPWpGaD
Pyrazinamide—CYP3A4—Metabolism—SULT4A1—coronary artery disease	2.39e-05	0.000171	CbGpPWpGaD
Pyrazinamide—CYP3A4—Metabolism—PYGM—coronary artery disease	2.39e-05	0.000171	CbGpPWpGaD
Pyrazinamide—CYP3A4—Biological oxidations—POMC—coronary artery disease	2.38e-05	0.00017	CbGpPWpGaD
Pyrazinamide—CYP1A2—Metabolism of lipids and lipoproteins—CTGF—coronary artery disease	2.37e-05	0.00017	CbGpPWpGaD
Pyrazinamide—AOX1—Metabolism—NOS3—coronary artery disease	2.35e-05	0.000168	CbGpPWpGaD
Pyrazinamide—CYP1A2—Metabolism of lipids and lipoproteins—HMGCR—coronary artery disease	2.35e-05	0.000168	CbGpPWpGaD
Pyrazinamide—CYP1A2—Metabolism—PYGB—coronary artery disease	2.34e-05	0.000168	CbGpPWpGaD
Pyrazinamide—CYP1A2—Metabolism—CKB—coronary artery disease	2.34e-05	0.000168	CbGpPWpGaD
Pyrazinamide—XDH—Metabolism—ALB—coronary artery disease	2.29e-05	0.000163	CbGpPWpGaD
Pyrazinamide—CYP1A2—Metabolism—COX5B—coronary artery disease	2.2e-05	0.000158	CbGpPWpGaD
Pyrazinamide—CYP1A2—Metabolism—DLAT—coronary artery disease	2.2e-05	0.000158	CbGpPWpGaD
Pyrazinamide—CYP1A2—Metabolism—PLIN1—coronary artery disease	2.2e-05	0.000158	CbGpPWpGaD
Pyrazinamide—CYP1A2—Metabolism—PFKFB3—coronary artery disease	2.2e-05	0.000158	CbGpPWpGaD
Pyrazinamide—CYP1A2—Metabolism—GSTM2—coronary artery disease	2.2e-05	0.000158	CbGpPWpGaD
Pyrazinamide—XDH—Metabolism—NOS3—coronary artery disease	2.19e-05	0.000156	CbGpPWpGaD
Pyrazinamide—AOX1—Metabolism—PTGS2—coronary artery disease	2.15e-05	0.000154	CbGpPWpGaD
Pyrazinamide—CYP3A4—Metabolism—GK—coronary artery disease	2.13e-05	0.000152	CbGpPWpGaD
Pyrazinamide—CYP3A4—Metabolism—LDHA—coronary artery disease	2.13e-05	0.000152	CbGpPWpGaD
Pyrazinamide—CYP3A4—Metabolism—HMGCS2—coronary artery disease	2.13e-05	0.000152	CbGpPWpGaD
Pyrazinamide—CYP3A4—Metabolism—GYG1—coronary artery disease	2.13e-05	0.000152	CbGpPWpGaD
Pyrazinamide—CYP3A4—Metabolism—PFKM—coronary artery disease	2.13e-05	0.000152	CbGpPWpGaD
Pyrazinamide—CYP3A4—Metabolism—GATM—coronary artery disease	2.13e-05	0.000152	CbGpPWpGaD
Pyrazinamide—CYP1A2—Metabolism of lipids and lipoproteins—ABCA1—coronary artery disease	2.1e-05	0.00015	CbGpPWpGaD
Pyrazinamide—CYP1A2—Metabolism—SULT1E1—coronary artery disease	2.09e-05	0.000149	CbGpPWpGaD
Pyrazinamide—CYP3A4—Metabolism—AK1—coronary artery disease	2.03e-05	0.000145	CbGpPWpGaD
Pyrazinamide—CYP3A4—Metabolism—GCH1—coronary artery disease	2.03e-05	0.000145	CbGpPWpGaD
Pyrazinamide—CYP1A2—Metabolism of lipids and lipoproteins—GGT1—coronary artery disease	2.03e-05	0.000145	CbGpPWpGaD
Pyrazinamide—XDH—Metabolism—PTGS2—coronary artery disease	2e-05	0.000143	CbGpPWpGaD
Pyrazinamide—CYP1A2—Metabolism—AKR1B1—coronary artery disease	1.99e-05	0.000143	CbGpPWpGaD
Pyrazinamide—CYP1A2—Metabolism—HK2—coronary artery disease	1.99e-05	0.000143	CbGpPWpGaD
Pyrazinamide—CYP3A4—Metabolism—UGCG—coronary artery disease	1.95e-05	0.000139	CbGpPWpGaD
Pyrazinamide—CYP3A4—Metabolism—MDH2—coronary artery disease	1.95e-05	0.000139	CbGpPWpGaD
Pyrazinamide—CYP3A4—Metabolism—PPAT—coronary artery disease	1.95e-05	0.000139	CbGpPWpGaD
Pyrazinamide—CYP3A4—Metabolism—PLCD1—coronary artery disease	1.95e-05	0.000139	CbGpPWpGaD
Pyrazinamide—CYP1A2—Metabolism—SLC27A1—coronary artery disease	1.91e-05	0.000137	CbGpPWpGaD
Pyrazinamide—CYP1A2—Metabolism—LCAT—coronary artery disease	1.87e-05	0.000134	CbGpPWpGaD
Pyrazinamide—CYP1A2—Metabolism—CPT1B—coronary artery disease	1.87e-05	0.000134	CbGpPWpGaD
Pyrazinamide—CYP3A4—Metabolism—PGM1—coronary artery disease	1.87e-05	0.000134	CbGpPWpGaD
Pyrazinamide—AOX1—Disease—TGFB1—coronary artery disease	1.86e-05	0.000133	CbGpPWpGaD
Pyrazinamide—CYP1A2—Metabolism—APOA4—coronary artery disease	1.84e-05	0.000132	CbGpPWpGaD
Pyrazinamide—AOX1—Disease—MAPK1—coronary artery disease	1.82e-05	0.00013	CbGpPWpGaD
Pyrazinamide—CYP3A4—Metabolism—CKB—coronary artery disease	1.81e-05	0.000129	CbGpPWpGaD
Pyrazinamide—CYP3A4—Metabolism—PYGB—coronary artery disease	1.81e-05	0.000129	CbGpPWpGaD
Pyrazinamide—CYP1A2—Metabolism of lipids and lipoproteins—PPARGC1A—coronary artery disease	1.81e-05	0.000129	CbGpPWpGaD
Pyrazinamide—CYP1A2—Metabolism—PDHA1—coronary artery disease	1.78e-05	0.000127	CbGpPWpGaD
Pyrazinamide—CYP1A2—Metabolism—GCLM—coronary artery disease	1.78e-05	0.000127	CbGpPWpGaD
Pyrazinamide—CYP1A2—Metabolism of lipids and lipoproteins—APOB—coronary artery disease	1.72e-05	0.000123	CbGpPWpGaD
Pyrazinamide—CYP1A2—Metabolism—CYP11B2—coronary artery disease	1.72e-05	0.000123	CbGpPWpGaD
Pyrazinamide—CYP1A2—Metabolism—TXNRD1—coronary artery disease	1.72e-05	0.000123	CbGpPWpGaD
Pyrazinamide—CYP3A4—Metabolism—COX5B—coronary artery disease	1.7e-05	0.000122	CbGpPWpGaD
Pyrazinamide—CYP3A4—Metabolism—GSTM2—coronary artery disease	1.7e-05	0.000122	CbGpPWpGaD
Pyrazinamide—CYP3A4—Metabolism—DLAT—coronary artery disease	1.7e-05	0.000122	CbGpPWpGaD
Pyrazinamide—CYP3A4—Metabolism—PLIN1—coronary artery disease	1.7e-05	0.000122	CbGpPWpGaD
Pyrazinamide—CYP3A4—Metabolism—PFKFB3—coronary artery disease	1.7e-05	0.000122	CbGpPWpGaD
Pyrazinamide—CYP1A2—Metabolism—SLC22A3—coronary artery disease	1.69e-05	0.000121	CbGpPWpGaD
Pyrazinamide—CYP1A2—Metabolism—ARNTL—coronary artery disease	1.67e-05	0.000119	CbGpPWpGaD
Pyrazinamide—CYP1A2—Metabolism—HADH—coronary artery disease	1.67e-05	0.000119	CbGpPWpGaD
Pyrazinamide—CYP1A2—Metabolism of lipids and lipoproteins—LPL—coronary artery disease	1.64e-05	0.000118	CbGpPWpGaD
Pyrazinamide—CYP3A4—Metabolism—SULT1E1—coronary artery disease	1.61e-05	0.000115	CbGpPWpGaD
Pyrazinamide—CYP1A2—Metabolism of lipids and lipoproteins—GPX1—coronary artery disease	1.6e-05	0.000115	CbGpPWpGaD
Pyrazinamide—CYP1A2—Metabolism—PLA2G2A—coronary artery disease	1.58e-05	0.000113	CbGpPWpGaD
Pyrazinamide—CYP1A2—Metabolism—GPX2—coronary artery disease	1.58e-05	0.000113	CbGpPWpGaD
Pyrazinamide—CYP1A2—Metabolism—APOA2—coronary artery disease	1.58e-05	0.000113	CbGpPWpGaD
Pyrazinamide—AOX1—Disease—PIK3CA—coronary artery disease	1.58e-05	0.000113	CbGpPWpGaD
Pyrazinamide—CYP1A2—Metabolism—GPX4—coronary artery disease	1.56e-05	0.000112	CbGpPWpGaD
Pyrazinamide—CYP1A2—Metabolism—HK1—coronary artery disease	1.56e-05	0.000112	CbGpPWpGaD
Pyrazinamide—CYP1A2—Metabolism—ABCG5—coronary artery disease	1.56e-05	0.000112	CbGpPWpGaD
Pyrazinamide—CYP1A2—Metabolism—SULT1A1—coronary artery disease	1.56e-05	0.000112	CbGpPWpGaD
Pyrazinamide—CYP1A2—Metabolism of lipids and lipoproteins—CD36—coronary artery disease	1.56e-05	0.000112	CbGpPWpGaD
Pyrazinamide—CYP1A2—Metabolism—HADHA—coronary artery disease	1.55e-05	0.000111	CbGpPWpGaD
Pyrazinamide—CYP3A4—Metabolism—AKR1B1—coronary artery disease	1.54e-05	0.00011	CbGpPWpGaD
Pyrazinamide—CYP3A4—Metabolism—HK2—coronary artery disease	1.54e-05	0.00011	CbGpPWpGaD
Pyrazinamide—CYP1A2—Metabolism—GSTA1—coronary artery disease	1.53e-05	0.000109	CbGpPWpGaD
Pyrazinamide—CYP1A2—Metabolism—LPA—coronary artery disease	1.51e-05	0.000108	CbGpPWpGaD
Pyrazinamide—CYP3A4—Metabolism—SLC27A1—coronary artery disease	1.47e-05	0.000105	CbGpPWpGaD
Pyrazinamide—CYP1A2—Metabolism—PLCB3—coronary artery disease	1.46e-05	0.000105	CbGpPWpGaD
Pyrazinamide—CYP1A2—Metabolism—APOA5—coronary artery disease	1.45e-05	0.000104	CbGpPWpGaD
Pyrazinamide—CYP3A4—Metabolism—LCAT—coronary artery disease	1.45e-05	0.000103	CbGpPWpGaD
Pyrazinamide—CYP3A4—Metabolism—CPT1B—coronary artery disease	1.45e-05	0.000103	CbGpPWpGaD
Pyrazinamide—CYP1A2—Metabolism—P4HB—coronary artery disease	1.42e-05	0.000102	CbGpPWpGaD
Pyrazinamide—CYP3A4—Metabolism—APOA4—coronary artery disease	1.42e-05	0.000102	CbGpPWpGaD
Pyrazinamide—CYP1A2—Metabolism of lipids and lipoproteins—AGT—coronary artery disease	1.41e-05	0.000101	CbGpPWpGaD
Pyrazinamide—AOX1—Disease—IL6—coronary artery disease	1.4e-05	0.0001	CbGpPWpGaD
Pyrazinamide—CYP1A2—Metabolism—PLA2G1B—coronary artery disease	1.39e-05	9.97e-05	CbGpPWpGaD
Pyrazinamide—CYP1A2—Metabolism of lipids and lipoproteins—APOE—coronary artery disease	1.38e-05	9.86e-05	CbGpPWpGaD
Pyrazinamide—CYP3A4—Metabolism—PDHA1—coronary artery disease	1.37e-05	9.8e-05	CbGpPWpGaD
Pyrazinamide—CYP3A4—Metabolism—GCLM—coronary artery disease	1.37e-05	9.8e-05	CbGpPWpGaD
Pyrazinamide—CYP1A2—Metabolism of lipids and lipoproteins—APOA1—coronary artery disease	1.36e-05	9.74e-05	CbGpPWpGaD
Pyrazinamide—CYP3A4—Metabolism—CYP11B2—coronary artery disease	1.33e-05	9.49e-05	CbGpPWpGaD
Pyrazinamide—CYP3A4—Metabolism—TXNRD1—coronary artery disease	1.33e-05	9.49e-05	CbGpPWpGaD
Pyrazinamide—AOX1—Metabolism—PIK3CA—coronary artery disease	1.32e-05	9.46e-05	CbGpPWpGaD
Pyrazinamide—CYP1A2—Metabolism—VCAN—coronary artery disease	1.31e-05	9.4e-05	CbGpPWpGaD
Pyrazinamide—CYP3A4—Metabolism—SLC22A3—coronary artery disease	1.31e-05	9.35e-05	CbGpPWpGaD
Pyrazinamide—CYP1A2—Metabolism—ALDOA—coronary artery disease	1.3e-05	9.32e-05	CbGpPWpGaD
Pyrazinamide—AOX1—Disease—AKT1—coronary artery disease	1.29e-05	9.23e-05	CbGpPWpGaD
Pyrazinamide—CYP3A4—Metabolism—ARNTL—coronary artery disease	1.29e-05	9.22e-05	CbGpPWpGaD
Pyrazinamide—CYP3A4—Metabolism—HADH—coronary artery disease	1.29e-05	9.22e-05	CbGpPWpGaD
Pyrazinamide—CYP1A2—Metabolism—DCN—coronary artery disease	1.27e-05	9.05e-05	CbGpPWpGaD
Pyrazinamide—CYP1A2—Metabolism—ALDH2—coronary artery disease	1.23e-05	8.8e-05	CbGpPWpGaD
Pyrazinamide—XDH—Metabolism—PIK3CA—coronary artery disease	1.23e-05	8.8e-05	CbGpPWpGaD
Pyrazinamide—CYP3A4—Metabolism—APOA2—coronary artery disease	1.22e-05	8.74e-05	CbGpPWpGaD
Pyrazinamide—CYP3A4—Metabolism—PLA2G2A—coronary artery disease	1.22e-05	8.74e-05	CbGpPWpGaD
Pyrazinamide—CYP3A4—Metabolism—GPX2—coronary artery disease	1.22e-05	8.74e-05	CbGpPWpGaD
Pyrazinamide—CYP3A4—Metabolism—SULT1A1—coronary artery disease	1.21e-05	8.63e-05	CbGpPWpGaD
Pyrazinamide—CYP3A4—Metabolism—GPX4—coronary artery disease	1.21e-05	8.63e-05	CbGpPWpGaD
Pyrazinamide—CYP3A4—Metabolism—ABCG5—coronary artery disease	1.21e-05	8.63e-05	CbGpPWpGaD
Pyrazinamide—CYP3A4—Metabolism—HK1—coronary artery disease	1.21e-05	8.63e-05	CbGpPWpGaD
Pyrazinamide—CYP1A2—Metabolism of lipids and lipoproteins—PPARG—coronary artery disease	1.2e-05	8.58e-05	CbGpPWpGaD
Pyrazinamide—CYP1A2—Metabolism—CYP2C19—coronary artery disease	1.2e-05	8.58e-05	CbGpPWpGaD
Pyrazinamide—CYP1A2—Metabolism—PIK3C2A—coronary artery disease	1.2e-05	8.58e-05	CbGpPWpGaD
Pyrazinamide—CYP1A2—Metabolism—LIPC—coronary artery disease	1.2e-05	8.58e-05	CbGpPWpGaD
Pyrazinamide—CYP1A2—Metabolism—HBA1—coronary artery disease	1.2e-05	8.58e-05	CbGpPWpGaD
Pyrazinamide—CYP3A4—Metabolism—HADHA—coronary artery disease	1.19e-05	8.53e-05	CbGpPWpGaD
Pyrazinamide—CYP1A2—Metabolism—APOC3—coronary artery disease	1.19e-05	8.53e-05	CbGpPWpGaD
Pyrazinamide—CYP1A2—Metabolism—LDLR—coronary artery disease	1.19e-05	8.48e-05	CbGpPWpGaD
Pyrazinamide—CYP1A2—Metabolism of lipids and lipoproteins—POMC—coronary artery disease	1.18e-05	8.47e-05	CbGpPWpGaD
Pyrazinamide—CYP3A4—Metabolism—GSTA1—coronary artery disease	1.18e-05	8.43e-05	CbGpPWpGaD
Pyrazinamide—CYP1A2—Metabolism—SLC9A1—coronary artery disease	1.17e-05	8.37e-05	CbGpPWpGaD
Pyrazinamide—CYP1A2—Metabolism—GSTT1—coronary artery disease	1.17e-05	8.37e-05	CbGpPWpGaD
Pyrazinamide—CYP3A4—Metabolism—LPA—coronary artery disease	1.17e-05	8.34e-05	CbGpPWpGaD
Pyrazinamide—CYP1A2—Metabolism—CETP—coronary artery disease	1.16e-05	8.28e-05	CbGpPWpGaD
Pyrazinamide—CYP1A2—Metabolism—GCLC—coronary artery disease	1.16e-05	8.28e-05	CbGpPWpGaD
Pyrazinamide—CYP1A2—Metabolism—SDC1—coronary artery disease	1.14e-05	8.19e-05	CbGpPWpGaD
Pyrazinamide—CYP3A4—Metabolism—PLCB3—coronary artery disease	1.13e-05	8.07e-05	CbGpPWpGaD
Pyrazinamide—CYP3A4—Metabolism—APOA5—coronary artery disease	1.12e-05	7.99e-05	CbGpPWpGaD
Pyrazinamide—CYP3A4—Metabolism—P4HB—coronary artery disease	1.1e-05	7.84e-05	CbGpPWpGaD
Pyrazinamide—CYP1A2—Metabolism—PSMA6—coronary artery disease	1.08e-05	7.73e-05	CbGpPWpGaD
Pyrazinamide—CYP1A2—Metabolism—PSMB5—coronary artery disease	1.08e-05	7.73e-05	CbGpPWpGaD
Pyrazinamide—AOX1—Metabolism—AKT1—coronary artery disease	1.08e-05	7.73e-05	CbGpPWpGaD
Pyrazinamide—CYP1A2—Metabolism of lipids and lipoproteins—ALB—coronary artery disease	1.08e-05	7.72e-05	CbGpPWpGaD
Pyrazinamide—CYP3A4—Metabolism—PLA2G1B—coronary artery disease	1.08e-05	7.69e-05	CbGpPWpGaD
Pyrazinamide—CYP1A2—Metabolism—CTGF—coronary artery disease	1.06e-05	7.55e-05	CbGpPWpGaD
Pyrazinamide—CYP1A2—Metabolism—HMGCR—coronary artery disease	1.05e-05	7.49e-05	CbGpPWpGaD
Pyrazinamide—CYP1A2—Metabolism—GOT2—coronary artery disease	1.05e-05	7.49e-05	CbGpPWpGaD
Pyrazinamide—CYP3A4—Metabolism—VCAN—coronary artery disease	1.01e-05	7.25e-05	CbGpPWpGaD
Pyrazinamide—CYP3A4—Metabolism—ALDOA—coronary artery disease	1.01e-05	7.2e-05	CbGpPWpGaD
Pyrazinamide—XDH—Metabolism—AKT1—coronary artery disease	1.01e-05	7.19e-05	CbGpPWpGaD
Pyrazinamide—CYP3A4—Metabolism—DCN—coronary artery disease	9.77e-06	6.99e-05	CbGpPWpGaD
Pyrazinamide—CYP1A2—Metabolism—PLCB1—coronary artery disease	9.63e-06	6.88e-05	CbGpPWpGaD
Pyrazinamide—CYP3A4—Metabolism—ALDH2—coronary artery disease	9.5e-06	6.8e-05	CbGpPWpGaD
Pyrazinamide—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—coronary artery disease	9.45e-06	6.75e-05	CbGpPWpGaD
Pyrazinamide—CYP1A2—Metabolism—ABCA1—coronary artery disease	9.33e-06	6.67e-05	CbGpPWpGaD
Pyrazinamide—CYP3A4—Metabolism—PIK3C2A—coronary artery disease	9.26e-06	6.62e-05	CbGpPWpGaD
Pyrazinamide—CYP3A4—Metabolism—HBA1—coronary artery disease	9.26e-06	6.62e-05	CbGpPWpGaD
Pyrazinamide—CYP3A4—Metabolism—LIPC—coronary artery disease	9.26e-06	6.62e-05	CbGpPWpGaD
Pyrazinamide—CYP3A4—Metabolism—CYP2C19—coronary artery disease	9.26e-06	6.62e-05	CbGpPWpGaD
Pyrazinamide—CYP3A4—Metabolism—APOC3—coronary artery disease	9.21e-06	6.58e-05	CbGpPWpGaD
Pyrazinamide—CYP3A4—Metabolism—LDLR—coronary artery disease	9.15e-06	6.54e-05	CbGpPWpGaD
Pyrazinamide—CYP3A4—Metabolism—SLC9A1—coronary artery disease	9.04e-06	6.46e-05	CbGpPWpGaD
Pyrazinamide—CYP3A4—Metabolism—GSTT1—coronary artery disease	9.04e-06	6.46e-05	CbGpPWpGaD
Pyrazinamide—CYP1A2—Metabolism—GGT1—coronary artery disease	9.04e-06	6.46e-05	CbGpPWpGaD
Pyrazinamide—CYP1A2—Metabolism—GOT1—coronary artery disease	9.04e-06	6.46e-05	CbGpPWpGaD
Pyrazinamide—CYP3A4—Metabolism—GCLC—coronary artery disease	8.94e-06	6.39e-05	CbGpPWpGaD
Pyrazinamide—CYP3A4—Metabolism—CETP—coronary artery disease	8.94e-06	6.39e-05	CbGpPWpGaD
Pyrazinamide—CYP3A4—Metabolism—SDC1—coronary artery disease	8.84e-06	6.32e-05	CbGpPWpGaD
Pyrazinamide—CYP3A4—Metabolism—PSMB5—coronary artery disease	8.35e-06	5.97e-05	CbGpPWpGaD
Pyrazinamide—CYP3A4—Metabolism—PSMA6—coronary artery disease	8.35e-06	5.97e-05	CbGpPWpGaD
Pyrazinamide—CYP3A4—Metabolism—CTGF—coronary artery disease	8.15e-06	5.83e-05	CbGpPWpGaD
Pyrazinamide—CYP1A2—Metabolism—GSTP1—coronary artery disease	8.12e-06	5.8e-05	CbGpPWpGaD
Pyrazinamide—CYP3A4—Metabolism—GOT2—coronary artery disease	8.08e-06	5.78e-05	CbGpPWpGaD
Pyrazinamide—CYP3A4—Metabolism—HMGCR—coronary artery disease	8.08e-06	5.78e-05	CbGpPWpGaD
Pyrazinamide—CYP1A2—Metabolism—PPARGC1A—coronary artery disease	8.04e-06	5.75e-05	CbGpPWpGaD
Pyrazinamide—CYP1A2—Metabolism—HMOX1—coronary artery disease	8.01e-06	5.72e-05	CbGpPWpGaD
Pyrazinamide—CYP1A2—Metabolism—CAT—coronary artery disease	7.9e-06	5.65e-05	CbGpPWpGaD
Pyrazinamide—CYP1A2—Metabolism—APOB—coronary artery disease	7.67e-06	5.48e-05	CbGpPWpGaD
Pyrazinamide—CYP1A2—Metabolism—GSTM1—coronary artery disease	7.46e-06	5.33e-05	CbGpPWpGaD
Pyrazinamide—CYP3A4—Metabolism—PLCB1—coronary artery disease	7.43e-06	5.31e-05	CbGpPWpGaD
Pyrazinamide—CYP1A2—Metabolism—LPL—coronary artery disease	7.32e-06	5.24e-05	CbGpPWpGaD
Pyrazinamide—CYP3A4—Metabolism—ABCA1—coronary artery disease	7.2e-06	5.15e-05	CbGpPWpGaD
Pyrazinamide—CYP1A2—Metabolism—GPX1—coronary artery disease	7.15e-06	5.11e-05	CbGpPWpGaD
Pyrazinamide—CYP3A4—Metabolism—GGT1—coronary artery disease	6.98e-06	4.99e-05	CbGpPWpGaD
Pyrazinamide—CYP3A4—Metabolism—GOT1—coronary artery disease	6.98e-06	4.99e-05	CbGpPWpGaD
Pyrazinamide—CYP1A2—Metabolism—CD36—coronary artery disease	6.96e-06	4.98e-05	CbGpPWpGaD
Pyrazinamide—CYP1A2—Metabolism—PPP2CA—coronary artery disease	6.87e-06	4.91e-05	CbGpPWpGaD
Pyrazinamide—CYP1A2—Metabolism—MTHFR—coronary artery disease	6.59e-06	4.71e-05	CbGpPWpGaD
Pyrazinamide—CYP3A4—Metabolism—GSTP1—coronary artery disease	6.27e-06	4.48e-05	CbGpPWpGaD
Pyrazinamide—CYP1A2—Metabolism—AGT—coronary artery disease	6.27e-06	4.48e-05	CbGpPWpGaD
Pyrazinamide—CYP3A4—Metabolism—PPARGC1A—coronary artery disease	6.21e-06	4.44e-05	CbGpPWpGaD
Pyrazinamide—CYP3A4—Metabolism—HMOX1—coronary artery disease	6.18e-06	4.42e-05	CbGpPWpGaD
Pyrazinamide—CYP1A2—Metabolism—APOE—coronary artery disease	6.14e-06	4.39e-05	CbGpPWpGaD
Pyrazinamide—CYP3A4—Metabolism—CAT—coronary artery disease	6.1e-06	4.36e-05	CbGpPWpGaD
Pyrazinamide—CYP1A2—Metabolism—APOA1—coronary artery disease	6.07e-06	4.34e-05	CbGpPWpGaD
Pyrazinamide—CYP3A4—Metabolism—APOB—coronary artery disease	5.92e-06	4.23e-05	CbGpPWpGaD
Pyrazinamide—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CA—coronary artery disease	5.81e-06	4.15e-05	CbGpPWpGaD
Pyrazinamide—CYP3A4—Metabolism—GSTM1—coronary artery disease	5.76e-06	4.12e-05	CbGpPWpGaD
Pyrazinamide—CYP3A4—Metabolism—LPL—coronary artery disease	5.65e-06	4.04e-05	CbGpPWpGaD
Pyrazinamide—CYP3A4—Metabolism—GPX1—coronary artery disease	5.51e-06	3.94e-05	CbGpPWpGaD
Pyrazinamide—CYP3A4—Metabolism—CD36—coronary artery disease	5.37e-06	3.84e-05	CbGpPWpGaD
Pyrazinamide—CYP1A2—Metabolism—PPARG—coronary artery disease	5.35e-06	3.82e-05	CbGpPWpGaD
Pyrazinamide—CYP3A4—Metabolism—PPP2CA—coronary artery disease	5.3e-06	3.79e-05	CbGpPWpGaD
Pyrazinamide—CYP1A2—Metabolism—POMC—coronary artery disease	5.27e-06	3.77e-05	CbGpPWpGaD
Pyrazinamide—CYP3A4—Metabolism—MTHFR—coronary artery disease	5.09e-06	3.64e-05	CbGpPWpGaD
Pyrazinamide—CYP3A4—Metabolism—AGT—coronary artery disease	4.84e-06	3.46e-05	CbGpPWpGaD
Pyrazinamide—CYP1A2—Metabolism—ALB—coronary artery disease	4.81e-06	3.44e-05	CbGpPWpGaD
Pyrazinamide—CYP3A4—Metabolism—APOE—coronary artery disease	4.74e-06	3.39e-05	CbGpPWpGaD
Pyrazinamide—CYP3A4—Metabolism—APOA1—coronary artery disease	4.68e-06	3.35e-05	CbGpPWpGaD
Pyrazinamide—CYP1A2—Metabolism—NOS3—coronary artery disease	4.6e-06	3.29e-05	CbGpPWpGaD
Pyrazinamide—CYP1A2—Metabolism—PTGS2—coronary artery disease	4.21e-06	3.01e-05	CbGpPWpGaD
Pyrazinamide—CYP3A4—Metabolism—PPARG—coronary artery disease	4.13e-06	2.95e-05	CbGpPWpGaD
Pyrazinamide—CYP3A4—Metabolism—POMC—coronary artery disease	4.07e-06	2.91e-05	CbGpPWpGaD
Pyrazinamide—CYP3A4—Metabolism—ALB—coronary artery disease	3.71e-06	2.65e-05	CbGpPWpGaD
Pyrazinamide—CYP3A4—Metabolism—NOS3—coronary artery disease	3.55e-06	2.54e-05	CbGpPWpGaD
Pyrazinamide—CYP3A4—Metabolism—PTGS2—coronary artery disease	3.25e-06	2.32e-05	CbGpPWpGaD
Pyrazinamide—CYP1A2—Metabolism—PIK3CA—coronary artery disease	2.59e-06	1.85e-05	CbGpPWpGaD
Pyrazinamide—CYP1A2—Metabolism—AKT1—coronary artery disease	2.11e-06	1.51e-05	CbGpPWpGaD
Pyrazinamide—CYP3A4—Metabolism—PIK3CA—coronary artery disease	2e-06	1.43e-05	CbGpPWpGaD
Pyrazinamide—CYP3A4—Metabolism—AKT1—coronary artery disease	1.63e-06	1.17e-05	CbGpPWpGaD
